The role of pro-angiogenic factors and angiogenesis inhibitors in diabetic nephropathy
Maeshima, Y.; Makino, H.
Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 9): 396-400
2010
ISSN/ISBN: 0047-1852 PMID: 21667492 Document Number: 647839
Document emailed within 1 workday
Related Documents
Siebert, J.; Reiwer-Gostomska, M. 2009: The role of angiogenic growth factors in the development of diabetic complications Kardiologia Polska 67(1): 62-64Grosicki, S.; Grosicka, A.; Hołowiecki, J. 2007: Clinical importance of angiogenesis and angiogenic factors in oncohematology Wiadomosci Lekarskie 60(1-2): 39-46
Zhou, Y.; Guo, L.-x.; Yu, D.-n.; Zhou, L.; Wang, Y.; Mou, Z.-q.; Wang, X.-x.; Zhang, L.-n.; Li, M. 2012: Analyses on the relative factors regarding diabetic nephropathy among 1758 cases of type 2 diabetic patients Zhonghua Liu Xing Bing Xue Za Zhi 33(6): 610-613
Shestakova, M.V.; Koshel', L.V.; Vagodin, V.A.; Dedov, I.I. 2006: Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis Terapevticheskii Arkhiv 78(5): 60-64
Giles, F.J. 2002: The emerging role of angiogenesis inhibitors in hematologic malignancies Oncology 16(5 Suppl 4: 23-29
Fiedler, W.; Staib, P.; Kuse, R.; Dührsen, U.; Flasshove, M.; Cavalli, F.; Hossfeld, D.K.; Berdel, W.E. 2001: Role of angiogenesis inhibitors in acute myeloid leukemia Cancer Journal 7(Suppl 3): S129-S133
Huddle, K.; Milne, F.J. 1991: Should ACE inhibitors be the drugs of choice in the treatment of hypertension in diabetes mellitus? ACE inhibitors are the drugs of choice in diabetic nephropathy South African Medical Journal 80(5): Suppl 10
Tagiyeva, I.; Aliyeva, S.; Bagirova, S.; Shamsadinskaya, N.; Agaeva, K. 2017: The Role of Angiogenic Factors in the Diagnostics of Pregnancy Complicated with Preeclampsia Georgian Medical News 2017(268-269): 35-38
Rudberg, S. 2000: Perinatal factors can be risk factors of diabetic nephropathy Lakartidningen 97(4): 317-319
Bolander, A.; Wagenius, G.; Larsson, A.; Brattström, D.; Ullenhag, G.; Hesselius, P.; Ekman, S.; Bergqvist, M. 2007: The role of circulating angiogenic factors in patients operated on for localized malignant melanoma Anticancer Research 27(5a): 3211-3217
Popova, E.N.; Lebedeva, M.V.; Ponomarev, A.B.; Popova, I.A.; Fomin, V.V. 2014: Interstitial pulmonary fibrosis: the role of angiogenic factors, the inhibitory pathways of progression Terapevticheskii Arkhiv 86(8): 23-28
Saha, T.; Halder, M.; Das, A.; Das, S.K. 2013: Role of nitric oxide, angiogenic growth factors and biochemical analysis in preeclampsia Indian Journal of Biochemistry and Biophysics 50(5): 462-466
Plouet, J. 1999: Angiogenesis and tumor growth. Angiogenic factors and tumor growth Annales de Pathologie 19(5 Suppl): S70-S71
Yamahara, K.; Yamahara, M.; Kume, S. 2017: Role of autophagy in diabetic nephropathy Nihon Jinzo Gakkai Shi 59(2): 50-57
Trevisan, R.; Viberti, G. 1995: Genetic factors in the development of diabetic nephropathy Journal of Laboratory and Clinical Medicine 126(4): 342-349
Ogawa, D.; Makino, H. 2012: Pathogenesis of diabetic nephropathy: the role of inflammation Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 5): 389-392
Martina, V.; Maestroni, A.; Maestroni, S.; Zerbini, G. 2010: Role of C-peptide in the pathogenesis of diabetic nephropathy Giornale Italiano di Nefrologia: Organo Ufficiale Della Societa Italiana di Nefrologia 27(3): 240-248
Blaslov, K.; Bulum, T.; Duvnjak, L. 2014: Pathophysiological factors in the development of diabetic nephropathy--new insights Acta Medica Croatica: Casopis Hravatske Akademije Medicinskih Znanosti 68(2): 135-140
Dalla Vestra, M.; Saller, A.; Mauer, M.; Fioretto, P. 2001: Role of mesangial expansion in the pathogenesis of diabetic nephropathy Journal of Nephrology 14(Suppl 4): S51-S57
Krairittichai, U.; Potisat, S.; Jongsareejit, A.; Sattaputh, C. 2011: Prevalence and risk factors of diabetic nephropathy among Thai patients with type 2 diabetes mellitus Journal of the Medical Association of Thailand 94(Suppl 2): S1-S5